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ABSTRACT - Background: Colorectal cancer is one of the most common types of neoplasia among 
the worldwide adult population. Among neoplasms of the gastrointestinal tract, it is ranked 
second in relation to prevalence and mortality, but its etiology is only known in around 5% of 
the cases. It is believed that 15% of malignant diseases are related to viral oncogenesis. Aim: To 
correlate the presence of HPV with the staging and degree of cell differentiation among patients 
with colorectal adenocarcinoma. Methods: A retrospective case-control study was conducted on 
144 patients divided between a test group of 79 cases of colorectal cancer and a control group to 
analyze 144 patients aged 25 to 85 years (mean, 57.85 years; standard deviation, 15.27 years and 
median, 58 years). Eighty-six patients (59.7%) were male. For both groups, tissue samples from 
paraffin blocks were subjected to DNA extraction followed by the polymerase chain reaction 
using generic and specific primers for HPV 16 and 18. Dot blot hybridization was also performed 
with the aim of identifying HPV DNA. Results: The groups were shown to be homogenous 
regarding sex, age and site of HPV findings in the samples analyzed. Out of the 41 patients with 
HPV, 36 (45.6%) were in the cases and five (7.7%) were in the control group (p<0.001). All the 
HPV cases observed comprised HPV 16, and HPV 18 was not shown in any of the cases studied. 
There were no significant differences in comparisons of sex, age and site regarding the presence 
of HPV in either of the groups. It was not observe any significant difference in relation to staging 
or degree of cell differentiation among the patients with colorectal cancer. Conclusion: Human 
papillomavirus type 16 is present in individuals with colorectal carcinoma. However, its presence 
was unrelated to staging or degree of differentiation.
RESUMO - Racional: O câncer colorretal é uma das neoplasias mais frequentes entre a população 
adulta mundial, e entre as do trato gastrointestinal, é a segunda em relação à prevalência e 
mortalidade sendo a sua causa conhecida apenas em cerca de 5% dos casos. Acredita-se que 
15% das doenças malignas estariam relacionadas à oncogênese viral. Objetivo: Correlacionar a 
presença do HPV com o estadiamento e o grau de diferenciação celular dos pacientes portadores 
de adenocarcinoma colorretal. Métodos: Foi realizado um estudo retrospectivo do tipo caso-
controle com 144 pacientes divididos em um grupo teste representado por pacientes com câncer 
colorretal em um total de 79 casos e um grupo controle correspondente à pacientes com doença 
benigna totalizando 65 casos. Após a aplicação dos critérios de exclusão, foi possível analisar 144 
pacientes com idade entre 25 a 85 anos (média de 57,85 anos com desvio-padrão de 15,27 anos 
e mediana de 58 anos). Oitenta e seis (59,7%) pacientes eram homens. Amostras teciduais a partir 
de blocos de parafina de ambos os grupos foram submetidos à extração do DNA e em seguida 
foi realizada reação em cadeia da polimerase com iniciadores genéricos e específicos para HPV 
16 e 18 e também a hibridização do tipo dot blot com o intuito de identificar o DNA do HPV. 
Resultados: Os grupos se mostraram homogêneos quanto a sexo, idade e localização do HPV nas 
amostras analisadas. Dos 41 pacientes com HPV, 36 (45,6%) eram do grupo teste e cinco (7,7%) do 
grupo controle (p<0,001). Todos os casos de HPV observados correspondiam ao HPV 16 não sendo 
evidenciado HPV 18 em nenhum caso estudado. Não houve diferença significativa na comparação 
realizada quando se considerou o sexo, idade e localização no que tange a presença do HPV em 
ambos os grupos. Não observou-se diferença significativa em relação ao estádio e ao grau de 
diferenciação celular dos pacientes portadores de câncer colorretal. Conclusão: O papilomavírus 
humano tipo 16 está presente em indivíduos portadores de carcinoma colorretal. No entanto, não 
está relacionado com o estadiamento e o grau de diferenciação.
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INTRODUCTION
Colorectal cancer is a multifactorial disease and can be studied from its earliest to the most advanced forms, making possible to understand the mechanisms that could be involved in its development. It can be highlighted 
the multiple genetic steps related to the carcinogenesis process28.
There is evidence that dietary and environmental factors play an important role in 
the development of colorectal cancer19. According to Giuliani7, several factors could be 
involved in colorectal carcinogenesis including factors relating to lifestyle, sequential 
genetic alterations and viral infection.   
The human papillomavirus (HPV) is the cause of one of the most prevalent sexually 
transmitted diseases in the world, and there are studies in the medical literature that 
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correlate it with the development of adenocarcinoma in 
the colon2,3,5,18. However, it is most commonly related to the 
development of cancer of the anal canal 3,12,24 and especially 
the uterine cervix15,16,21,26,27.
Because of these data and the already confirmed 
carcinogenic potential of HPV in the cervix and anal 
canal, detection and identification of papillomavirus as a 
predisposing factor for colorectal carcinogenesis is necessary. 
This may allow identification of risk groups and assist in the 
development of new therapies based on understanding the 
biology of this disease18. 
Based on the findings in the literature, these authors 
were motivated to conduct this study to search for a possible 
association between HPV and colorectal adenocarcinoma, 
along with the possibility of a relationship with prognostic 
factors for this disease, such as the patients’ degree of cell 
differentiation and stage. 
METHODS
This study was reviewed and approved by the Research 
Ethics Committee of the Federal University of São Paulo, São 
Paulo, Brazil, under number 1377/08. This was a case-control 
study, conducted in partnership with the Ophyr Loyola 
Hospital and Ludwig Cancer Research Institute.
 
Patients
A total of 182 patients were initially selected for the 
study from January 1999 to December 2003. After applying 
the inclusion and exclusion criteria, the remaining patients 
were divided into two groups: 79 cases in the test group (TG) 
and 65 cases in the control group (CG). The inclusion criteria 
were that the patients needed to have been admitted to the 
Ophyr Loiola Hospital, Belém, PA, Brazil, for treatment and 
diagnostic investigation according to the group to which they 
were allocated, classified in accordance with the TNM system, 
with medical records and paraffin blocks representing the 
primary tumor, filed in the Department of Pathology, as well 
as blocks from the patients who only underwent a biopsy.
In cases in which it was not possible to obtain viable 
DNA for PCR, the patients were excluded. There were three 
such cases in the TG and 12 in the CG. Another five cases 
in the CG were excluded because they were diagnosed as 
adenomas. Patients who had undergone prior radiotherapy 
were also excluded. 
Regarding the descriptive data, the patients comprised 
40.3% females and 59.7% males. Most cases were beyond their 
5th decade (67.2%) and according to the location, 53.5% of 
lesions were located in the rectum. The distribution according 
to clinical stage consisted of 10 cases in stage I (12.7%), 27 
cases in stage II (34.2%), 26 cases in stage III (32.9%) and 
16 cases in stage IV (20.3%). All cases in the TG comprised 
samples from patients with colorectal adenocarcinoma. 
The CG consisted of one case of normal mucosa (0.7%), 
35 cases of inflammatory lesion of the mucosa (24.3%), 28 
cases of mucosal polypoid lesion (19.4%) and one case of 
hypoganglionosis (0.7%).
 
Histopathological diagnosis
After data collection, the tissue samples were 
immediately immersed in a buffered solution of 10% 
formaldehyde to preserve the material and were sent to the 
Pathology Division of the Ophyr Loyola Hospital. In this sector, 
the formalin-fixed specimens were embedded in paraffin and 
processed using standard histopathological techniques. The 
diagnostic evaluation was performed by pathologists of the 
institution and samples from the patients who fulfilled the 
criteria for the TG and CG were selected for the study. 
After this selection, the paraffin blocks containing 
genetic material from the selected cases were sectioned and 
sent in sterile tubes to the Ludwig Cancer Research Institute 
in São Paulo for the polymerase chain reaction (PCR) to be 
performed.
DNA extraction and PCR
Sections of paraffin-embedded tissues deposited in 
a tube were subjected to the deparaffinization process and 
enzymatic digestion with proteinase K (200 mg/ml) at 56 °C 
for 2-4 days. After digestion, DNA was extracted using the 
phenol-chloroform method recommended by Sambrook 22.
After extraction and purification, the DNA samples 
were subjected to PCR, using the primers PCO3 and G74 
(oligonucleotide primers used in PCR amplification reactions), 
which amplify 100 base pairs (bp) of the human b-globin 
gene1, with the aim of evaluating the adequacy and integrity 
of the DNA present in each sample.
The positive samples were subjected to PCR with 
generic primers for HPV (GP5+/GP6+8), capable of amplifying 
140 bp of the HPV L1 gene.
To demonstrate that there was no contamination by 
exogenous DNA, a negative control was used, containing all 
the reagents of the mixture except for the DNA. A lineage 
of HeLa cells containing DNA from integrated HPV 1826 was 
used as the positive control. 
The amplifications were performed in an Eppendorf 
thermocycler, Mastercycle gradient (Germany). Forty cycles of 
amplification were effected applying 1 min for denaturation 
at 95° C, 1 min for annealing at 55° C and 1.5 min for the chain 
elongation at 72° C.
The amplification products, also known as amplicons, 
were analyzed on 7% polyacrylamide gel stained with silver.
Identification of HPV by means of dot blot hybridization (Dot Blot)
This method is based on the general principles of 
hybridization, in which the amplified product is denatured 
and fixed through stitches onto a nylon membrane. The 
procedures for fixation of the amplicon onto the membrane 
include heating or UV irradiation. Then the membrane is 
coated with specific probes (singly or as cocktails) for HPV 
types 6, 11, 16, 18, 31, 33, 34, 35, 39, 40, 42, 43, 44, 45, 51, 52, 
54, 56 and 58, labeled with radioactive phosphorus (P32). The 
hybridization is revealed after exposure of the membranes 
to X-ray film for 18 to 36 h at 70° C. Hybridization with the 
probe is recognized as evidence that the nucleotide sequence 
searched for is present in the specimen.
It was used in each membrane, in addition to positive 
and negative controls for the PCR products, controls for 
different types of HPV, from PCR amplifications of clinical 
samples and plasmids.
After this, the membranes were wetted with 2xSSC 
solution and placed in a plastic bag with 5 ml of 6xSSC 
solution, 10x Denhardt’s, 0.5% SDS and 100 mg of denatured 
salmon sperm, and then were incubated at 55° C for three 
hours (pre-hybridization). 
Then, radioactive probes were added to the above 
solution, which was left to continue incubating at the same 
temperature for 12 to 24 h (hybridization). At the end of this 
period, the membranes were washed with 3xSSC solution 
and 0.5% SDS in three stages: the first for 10 min at room 
temperature; the other two for 30 min each at 55° C. Finally, 
the membranes were exposed to X-ray film (X-OmatK-Kodak) 
for 18 to 36 h at -70° C. The hybridization was observed after 
the film was developed, through the presence of dark spots 
at the location corresponding to the samples that were added 
to the membrane.
Specific PCR for E7 of HPV 16 and 18
The samples were used in a PCR with specific primers 
for E7 of HPV 16 and 18, with the capacity to amplify 217 
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bp for E7 of HPV 16 and 137 bp for E7 of HPV 18. Regarding 
specific primers for HPV 16, the following were used: 5´ GCC 
CAT TAA CAG GTC TTC C 3´; 5´ TTT GCA ACC AGA GAC AAC 
TGA 3´. For HPV 18: 5´ ATG TCA CGA GCA ATT AAG C 3´; 5´ TTC 
TGG CTT CAC ACT TCA AAC A 3´.
The amplifications were performed in an Eppendorf 
thermocycler, Mastercycle gradient model (Germany). Forty 
cycles of amplification were effected, applying 1 min for 
denaturation at 95° C, 1 min annealing at 55° C and 1.5 min 
for the chain elongation at 72° C.
The amplification products, also known as amplicons, 
were analyzed on 7% polyacrylamide gel stained with silver, 
analyzed in a way similar to what was done using generic PCR. 
Statistical analysis
The results were initially subjected to descriptive analysis 
on all the variables. For the quantitative variables, this analysis 
was done by observing the minimum and maximum values 
and calculating means, standard deviations and medians. For 
the qualitative variables, the absolute and relative frequencies 
were calculated. To test the homogeneity between the 
proportions, the chi-square test was used, or the Fisher exact 
test when the expected frequencies were less than five. 
The significance level for rejecting the hypothesis of nullity 
among the samples analyzed was established as 5%. 
RESULTS
While developing this study, three cases were excluded 
from the TG due to negative results from the human β globin 
gene test for identification of viable DNA. Likewise, in the CG, 
it was necessary to exclude eight cases. Another five cases 
were excluded because they referred to adenomas, and thus 
the total number in the CG was 65 cases. Seventy-nine cases 
in the TG showed positivity for the human β globin gene 
(92.9% the samples). 
After applying the exclusion criteria, were analyzed 
144 patients aged 25-85 years (mean of 57.85 years, with a 
standard deviation of 15.27 years, and median of 58 years). 
Eighty-six patients (59.7%) were male.
HPV was found to be present in 41 patients, representing 
28.5% of the total number of cases, being only identified 
the presence of HPV 16 in all the cases, and even using 
hybridization and PCR specific for HPV 18, this was not found 
in any of the cases.
Seventy-nine patients (54.9%) had colorectal 
adenocarcinoma and formed the TG. Sixty-five (45.1%) were 
taken to be members of the CG.
The groups did not differ significantly according to 
gender, age and tumor location, thus showing that there was 
homogeneity between them. 
Out of the 41 patients with HPV, 36 (45.6%) were in the 
TG and five (7.7%) in the CG. Thus, there was a significant 
difference between the groups (Table 1). The TG had a higher 
percentage of cases in which the presence of HPV was 
identified, compared with the CG (chi-square test; p< 0.001).
TABLE 1 – Patients’ characteristics according to the presence 
or absence of DNA of HPV in both study groups
                                             HPV
TG(%) CG(%) p
Positive 45,6 7,7
*p< 0,001Negative 54,4 92,3
Total 100 100  
(*) descriptive probability level of the chi-square test
Among the TG cases, there were no significant 
differences regarding gender, age or location in relation to 
the presence of HPV. The patients in the TG also did not show 
any significant difference in relation the stage or the degree 
of cell differentiation (Table 2).
TABLE 2 – Characteristics of 79 test group patients according 
to TNM stage, clinical stage and degree of 
cell differentiation regarding the presence 
or absence of HPV in absolute numbers and 
percentages 
Variable
HPV
Category Positive Negative pn % n %
Degree of 
Differentiation
I 4 11,1 8 18,6
0,269(2)II 26 72,2 31 72,1III 3 8,3 4 9,3
IV 3 8,3 0 0,0
T stage
1 1 2,8 1 2,3
0,877(2)2 5 13,9 8 18,63 27 75,0 29 67,4
4 3 8,3 5 11,6
N stage
0 17 47,2 25 58,1
0,613(1)1 11 30,6 11 25,6
2 8 22,2 7 16,3
M stage 0 28 77,8 35 81,4 0,690(1)1 8 22,2 8 18,6
Clinic stage I / II 14 38,9 23 53,5 0,195(1)III / IV 22 61,1 20 46,5
(1)descriptive probability level of the chi-square test; (2)descriptive probability level 
of the Fisher exact test 
 Regarding the location of HPV in relation to the 
collection site, no statistically significant difference was 
observed (Figure 1).
FIGURE 1 - Distribution of cases in relation to presence of 
HPV and sample collection site in both groups, 
represented as percentages (%)
DISCUSSION
Knowledge about the cellular and molecular 
mechanisms relating to colorectal cancer has been improving 
over recent years. However, even with advances in diagnostic 
and therapeutic methods such as surgery, chemotherapy 
and radiotherapy, the five-year survival rate remains around 
40%10. When treatment is performed in the early stages, this 
survival rate can reach 80%, whereas in cases of advanced 
disease, only 20% will still be alive after five years17.
According to Ponz de Leon20, specific etiology has 
only been established for 3.7% of colorectal cancer cases. 
The commonest of these causes is HNPCC, but the etiology 
remains unclear in the vast majority of the cases (96.3%).  
 Based on the literature investigated, it is can be 
affirmed that about 15% of neoplasms generally have 
viral etiology. This cause contributes towards human 
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carcinogenesis by favoring genetic instability and inducing 
chromosomal aberrations7.
Based on these data, it can pose questions regarding 
the possibility that a virus, HPV in this case, might promote 
changes that could result in development of colorectal 
cancer. This possibility could favor development of strategies 
to control this disease, which is responsible for high mortality 
and morbidity worldwide.
From these data, it is believed that the controversy 
that exists in the literature regarding the possible association 
between HPV and colorectal cancer is one of the most 
important justifications for the present study.
In comparing the two groups, it can be seen that the 
age variable was not significant, although the age of the 
patients in the CG was lower than the age in the GT. This was 
probably due to differences relating to occurrences of the 
malignant form of the disease, which is more common from 
the fifth decade of life onwards, thus differing from what is 
observed among controls, i.e. among individuals who are not 
cancer patients.
The variables of age, gender, and site involved did not 
show any differences, thus indicating that the groups were 
homogeneous.
In analyzing the cancer group regarding the presence 
or absence of HPV in relation to sex, age, tumor location and 
other variables associated with the prognosis any differences 
were found. Other authors have also not observed any 
differences in these variables2,4,5.
In studies that identified the presence of HPV at 
sites other than the colon, such as in cases of head and 
neck cancer25 and lung cancer6, it was observed that when 
significantly associated with HPV, these cancers were related 
to a better prognosis. However, these authors did not observe 
this relationship.
Through analyzing the variable of tumor location, it 
could be noted that papillomavirus DNA was present in both 
groups, and was most common in the region of the rectum. It 
was also found in other regions of the large intestine, but the 
difference was not significant. This may be related to forms 
of contamination in this region other than the retrograde 
pathway from the anogenital region.
PCR on HPV, using paraffin-embedded material, has 
specificity comparable to in situ hybridization. PCR using 
specific primers is able to amplify and detect small portions 
of the HPV genome of up to 119 bp, from fragments of HPV 
type 16 or 18, which is part of the E6 or E7 gene of HPV23. 
Dot Blot hybridization has been performed in several 
studies with the aim of detecting human papillomavirus DNA 
in material extracted by means of a biopsy on the uterine 
cervix11,16. This method has lower sensitivity and specificity 
than southern blot hybridization, which could explain the 
variation in the prevalence of HPV around the world, at various 
sites of the human body, depending on the techniques used 
for detecting HPV DNA. These variations from the techniques 
used may be underestimating the true prevalence of HPV11. 
Initially in this study, PCR was performed using generic 
primers for HPV (GP5+/GP6+)17, which were able to amplify 
140 bp of the HPV L1 gene. After this procedure, the samples 
were subjected to Dot Blot hybridization in order to identify 
HPV types 6, 11, 16, 18, 31, 33, 34, 35, 39, 40, 42, 43, 44, 45, 
51, 52, 54, 56 and 58. However, it was only possible to identify 
HPV 16. 
From these data, was chosen to perform PCR with 
specific primers for E7 in HPV 16 and 18, in accordance with 
the method proposed by Molina (2004)14, because other 
authors have demonstrated the presence of HPV 18 DNA in 
colorectal cancer samples2,5,9. 
 After conducting PCR with specific primers for E7 in 
HPV 16 and 18, it was not possible to identify HPV 18. These 
data are consistent with the findings of Weinberger (2004)30, 
who did not make reference in their results to any presence of 
HPV 18, through using real-time PCR, they only showed HPV 
16 and found a significant correlation with patients at an early 
stage. 
On the other hand, Lee9 identified the presence of 
HPV 18 DNA in about 84% of his samples, through PCR 
followed by southern blot hybridization for HPV 18 typing. 
These results were divergent from these data, possibly due to 
demographic differences, given that in the study by Lee9, the 
population was Asian, whereas here and in Weinberger30, it 
was in a western population. 
Bodagui2 showed that HPV 18 was present in only 13% 
of their samples. They concluded that HPV 16 (82% of the 
cases) may be related to development of colorectal cancer 
and that this would not be originated in the anogenital region, 
as there was higher incidence in the cecum and ascending 
colon, in a non significant way.
In previous studies that used detection techniques 
similar to what here was used, the presence of HPV ranged 
from 32% found by McGregor13 to 84% found by Lee9. Was 
observed in this study the presence of HPV 16 in 45.6% 
of the samples from patients with colorectal cancer and, 
in comparing them with the control group, was found a 
significant difference that may have been related to the 
development of colorectal cancer.
Unlike other authors, was showed that HPV 16 was 
present in 7.7% of the samples from patients in the CG. This 
may have been related to the tissue collection method, which 
was from colonoscopies, which could have contaminated the 
samples with HPV from the anogenital region.
In Brazil, the first study linking the presence of HPV 
with colorectal cancer was conducted in Rio Grande do Sul by 
Damin5, in which it was observed that 83.3% of the samples 
were positive for HPV DNA. Type 16 was the one most 
commonly found, representing approximately 68.3% of the 
cases, but this did not have any relationship with prognostic 
factors. However, it suggests that HPV may be associated with 
the pathogenesis of colorectal cancer. 
In this study, the prevalence of HPV was 45.6%, unlike 
the findings of Damin5. This variation may have been due to 
lower incidence of colorectal cancer in state of Pará than in Rio 
Grande do Sul. Another factor that may have been associated 
was that in this study, was used material from samples that 
had been embedded in paraffin for preservation, which is 
known to lead to the possibility of degradation of the DNA 
in the samples. This differed from the technique of Damin5, 
who used fresh material obtained during surgery that was 
preserved in liquid nitrogen.
In this study, was not found any significant association 
between the presence of HPV and the staging and degree of cell 
differentiation in patients with HPV, in comparison with cases 
in which this was not shown by the techniques that here used. 
Other authors who investigated this association also 
failed to demonstrate this association with colorectal cancer, 
as noted by Cheng4. The possibility that the use of archived 
and paraffin-embedded material may have been responsible 
for this lack of evidence cannot be ruled out. However, the 
study by Damin5 used fresh material obtained during surgery 
and was also unable to promote this association. 
The findings obtained over the course of this study 
coincide with data in the literature in which was observed 
the presence of HPV in tissue samples from patients with 
colorectal cancer. However, other authors did not identify HPV, 
and this could be related to the many different techniques for 
identifying HPV DNA used in these studies. 
It is possible to correlate the presence of HPV with 
colorectal cancer and in case of this study there was a 
relationship with HPV 16, but not with HPV 18.
Were observed some limitations over the course of this 
study, but these limitations do not invalidate the results. It 
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is believed that these conclusions may provide important 
contributions towards resolving the controversies that still 
persist even after the previous studies. Colorectal cancer is 
a disease of multifactorial origin and the demonstration that 
HPV is associated with it may favor alternatives for lessening 
the appearance of colorectal cancer.
Based on these data, was shown the presence of human 
papillomavirus in individuals with colorectal carcinoma 
and that this may be associated with cancer development. 
However, its presence was not related to the stage or degree 
of cell differentiation in the patients studied.
CONCLUSION
Human papillomavirus type 16 is present in individuals 
with colorectal carcinoma. However, its presence was 
unrelated to staging or degree of differentiation.
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